Advance Precision Medicine with patient-driven, multimodal data infrastructure
Access multimodal datasets at population scale
Axia’s platform supports data discovery, study feasibility and new evidence generation by enabling researchers to work with diverse, consented multimodal datasets.
Genomics, transcriptomics, proteomics, wearables, clinical biomarkers, and Real-World outcomes are accessible within our secure, compliant environments, on demand.
Enable compliant, consented collaborations with patients at scale
Our infrastructure allows sponsors to request access to anonymized, patient-contributed data and analyze federated cohorts without moving or duplicating data.
All activity occurs within audited, regulatory-ready workspaces designed for international collaborative research.
Generate deeper insights through responsible, opt-in patient engagement
Axia offers a structured channel for patient-initiated participation.
Sponsors can share studies, gather targeted real-world insights and follow longitudinal outcomes from users who choose to take part, all leveraging Axia’s transparent consent model.
Connect with Axia to shape the future of real-world, multimodal data research
Patrick C, Head of Biomarker Discovery
“Omics data is essential for work, research, but even the largest datasets cannot support every analytical question.
And when a dataset doesn’t have enough statistical power for your question, there is no way to add more data, especially when Omics is missing.
Axia’s model means we finally have a place to go to fill those evidence gaps.”
